Nurix Therapeutics
NRIX
NRIX
170 hedge funds and large institutions have $1.01B invested in Nurix Therapeutics in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 51 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3.01% less ownership
Funds ownership: 114.49% → 111.48% (-3%)
34% less capital invested
Capital invested by funds: $1.53B → $1.01B (-$523M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
170
Holding in Top 10
2
Calls
$777K
Puts
$96K
Top Buyers
| 1 | +$29.7M | |
| 2 | +$11.6M | |
| 3 | +$9.5M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$7.61M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$7.59M |
Top Sellers
| 1 | -$8.25M | |
| 2 | -$7.78M | |
| 3 | -$6.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.73M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$4.32M |
